SAFETY-A for Promoting Equity in Suicide Prevention Outcomes in Schools
Launched by UNIVERSITY OF CALIFORNIA, LOS ANGELES · Apr 25, 2023
Trial Information
Current as of November 14, 2025
Recruiting
Keywords
ClinConnect Summary
The SAFETY-A trial is focused on improving mental health services for young people, particularly those who may be having thoughts of suicide. The goal is to adapt a program called Safe Alternatives For Teens and Youth - Acute (SAFETY-A) for schools in areas that might not have enough resources. This program aims to help reduce differences in mental health service usage among students from different racial and ethnic backgrounds, especially Asian American and Latinx youth. The study will try out this program in several school districts to see how well it works and if it encourages more students to seek help when they are struggling.
To participate in this trial, students aged 11 to 19 who are enrolled in the school district and have shared thoughts or behaviors related to suicide can be included, as long as they have a caregiver who can also take part. However, students who are in immediate danger or unable to engage due to certain severe conditions will not be eligible. Those involved can expect to participate in a supportive program designed to help them express their feelings and connect with mental health resources. This trial is important because it seeks to create a more inclusive and effective approach to mental health support in schools, particularly for those who have been underserved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 11-19
- • 2. Enrolled in participating school district
- • 3. Present with suicide thoughts or behavior to school personnel
- • 4. Have an identified caregiver who can participate in the intervention
- Exclusion Criteria:
- • 1. School personnel determine the student to be at such imminent risk of danger to self that they are unable to benefit from the intervention and must be immediate transported for emergency care.
- • 2. Student is unable to participate in the intervention due to indications of intellectual disability, psychosis, or intoxication
About University Of California, Los Angeles
The University of California, Los Angeles (UCLA) is a prestigious academic institution renowned for its commitment to research and innovation in the biomedical field. As a clinical trial sponsor, UCLA leverages its cutting-edge facilities, expert faculty, and collaborative environment to advance medical knowledge and improve patient care. The university is dedicated to conducting rigorous clinical research that adheres to the highest ethical standards, aiming to translate scientific discoveries into effective therapies and interventions. Through its diverse array of clinical trials, UCLA seeks to address critical health challenges while fostering the development of future healthcare leaders.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Anna S Lau, PhD
Principal Investigator
University of California, Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported